» Articles » PMID: 23660008

[Normocalcemic Primary Hyperparathyroidism: Recommendations for Management and Follow-up]

Overview
Journal Endocrinol Nutr
Date 2013 May 11
PMID 23660008
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To provide practical recommendations for evaluation and follow-up of patients with normocalcemic primary hyperparathyroidism.

Participants: Members of the Bone Metabolism Working Group of the Spanish Society of Endocrinology.

Methods: A systematic search was made in MEDLINE (PubMed), using the terms normocalcemic primary hyperparathyroidism and primary hyperparathyroidism, for articles in English published before 22 November 2012. Literature was reviewed by 2 members of the Bone Metabolism Working Group of the Spanish Society of Endocrinology, and after development of recommendations, the manuscript was reviewed by all other members of the Group, and their suggestions were incorporated.

Conclusions: The document provides practical recommendations for evaluation and follow-up of patients with normocalcemic primary hyperparathyroidism. There is however little evidence available about different aspects of this disease, mainly progression rate and clinical impact. More data are therefore needed before definite recommendations may be made.

Citing Articles

Hypovitaminosis D masking hypercalcemia in primary hyperparathyroidism: case report.

Elsherbiny T Ther Adv Endocrinol Metab. 2023; 14:20420188231213208.

PMID: 38028332 PMC: 10656797. DOI: 10.1177/20420188231213208.


Epidemiology and management of parathyroid gland disorders in Spain over 15 years: A retrospective multicentre analysis.

Darba J, Marsa A PLoS One. 2020; 15(3):e0230130.

PMID: 32155210 PMC: 7064228. DOI: 10.1371/journal.pone.0230130.


Investigating patients with normocalcemic hyperparathyroidism: When is a parathyroid scintigraphy indicated?.

Mazokopakis E, Skarakis S World J Nucl Med. 2019; 18(3):227-231.

PMID: 31516364 PMC: 6714157. DOI: 10.4103/wjnm.WJNM_61_18.